DD Therapeutics, LLC

Biotech · Private

Nanoparticle-conjugated neuropeptide delivery system for brain targeting using receptor-mediated transcytosis

Grants
$150K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A nanotechnology approach to higher brain penetrance and sustained brain delivery of intranasal oxytocin$149,903
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1403PANACISE BIO, INC.——
1404On Target Therapeutics, LLC——
1405CRYOCRATE LLC——
1406DD Therapeutics, LLC——
1407Bedrock Therapeutics, Inc.——
1408Integrated Protein Technologies, Inc.——
1409PHOTONIC PHARMA, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.